| Characteristic | Supratentorial PNET | Medulloblastoma |
| Prevalence | <2% pediatric CNS tumors | ~20% pediatric CNS tumors |
| Mean age at presentation | 3 years | 5 years |
| Sex | Equal incidence | Males>females |
| Imaging | Heterogeneous enhancement Distinct border Poorly differentiated | Homogeneous enhancement |
| Histopathology | Neuroepithelial cells Small round nuclei | Same |
| Molecular biology | No specific chromosomal abnormalities | 17p deletion 17q addition |
| Metastasis | 5 – 39% | 40 – 60% |
| Treatment | Surgery Craniospinal XRT Chemotherapy | Same |
| 3-year progression-free survival | 45 – 49% | >80% |
Please create a free account or log in to read 'Differences Between Supratentorial PNET and Medulloblastoma (Infratentorial PNET) in Children'
The ISPN Guide and ISPN Library are one platform. Register once and complete your profile to access both resources.
